Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Formulation
Indian Pharmaceutical Market Grows 6.1% in October Against the Trend2024-11-15
Global healthcare encounters formidable challenges with AMR and sepsis, eyes pathogen sequencing to manage spread2024-09-20
Huadong Medicine Aussino Biotech Announce Exclusive Strategic Collaboration on Improved Oral Formulation of Edaravone in China Beyond2024-07-19
Hospital Director Illegally Profited 27 Million, Exposed by Discipline Inspection Commission!2024-07-19
Rising heart issues warrant urgent need for proactive heart health monitoring: Dr Manoj Durairaj2024-07-12
Jan Aushadhi Kendras report 36.7% growth in sales in May2024-07-03
Genetic Signatures’ EasyScreen gastrointestinal parasite detection kit receives US FDA clearance2024-06-07
Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis2024-06-07
US EPA, US FDA & USDA issue joint regulatory plan for biotechnology2024-05-14
WHO publishes new guidance aims to reduce bloodstream infections from catheter use2024-05-11
Top 10 countries accounted for Indias 63% of Ayush herbal products export in 2023-242024-05-11
Merck Collaborates with AI Biotech in times="32".4 Billion ADC Drug Development2024-04-17
Signant Health unveils next-level advancements in efficient, compliant IP management with updates to its clinical supply solutions2024-03-08
Unveiling the Pricing of Chinas Fifth Domestic CAR-T Therapy: Can Annual Sales Reach 1 Billion?2024-03-08
Unveiling the Future Direction of Innovative Medicines in 20242024-03-08
The Race to Market: Five Potential Blockbuster GLP-1 Therapies in 20242024-02-22
Enveric selects development candidates from EVM301 Series based on potential to minimize or eliminate the hallucinogenic effect of psychedelic-derived compounds2023-12-08
World Health Organization releases guidelines on chronic low back pain2023-12-08
Merck announces positive results from phase 2 KeyVibe-002 trial evaluating coformulation of vibostolimab pembrolizumab in previously treated patients with metastatic NSCLC2023-12-08
Global cell gene therapy market projected to expat 24% CAGR2023-11-15
Gilead Sciences Reports Q3 2023 Financial Results2023-11-10
Amgen to present results from phase 4 FOREMOST study of Otezla to treat early oligoarticular psoriatic arthritis at ACR 20232023-11-09
India’s mental healthcare grapples with stigma, inadequate resources & insufficient expertise2023-11-03
The Future of Personalized Medicine2023-11-03
Sanofi Shares Rebound as Company Announces Consumer Health Division Spinoff2023-11-03
Eli Lilly Collaborates with Redwire Corporation to Explore Drug Manufacturing in Space2023-11-03
Novartis Acquires FDA Priority Review Voucher from bluebird bio for $103 Million2023-11-03
Pfizer Receives Conditional Approval for Tislelizumab in the Treatment of Relapsed or Refractory Extranodal NK/T-cell Lymphoma (ENKTL)2023-11-03
Safety warnings to be provided to all patients with each medicine containing valproate they get under new law: MHRA2023-10-13
Novo Nordisk halts phase III FLOW trial of semaglutide early due to strong efficacy2023-10-13
Leqembi Receives Approval in Japan for the Treatment of Alzheimers Disease: A Milestone in Slowing Cognitive Decline2023-10-13
Indias Quest for Pharma Self-Sufficiency: Reducing Dependence on China2023-10-13
共1510个 页次:1/48页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463